Immix Biopharma, Inc. (IMMX)
US Market

Immix Biopharma, Inc. (IMMX) Financial Statements


Immix Biopharma, Inc. Financial Overview

Immix Biopharma, Inc.'s market cap is currently ―. The company's EPS TTM is $-0.948; its P/E ratio is -2.19; Immix Biopharma, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -4.34M$ -3.59M$ -2.49M$ -3.79M$ -1.53M
EBITDA$ -4.34M$ -3.59M$ -2.49M$ -3.79M$ -1.53M
Net Income Common Stockholders$ -4.28M$ -3.58M$ 2.57M$ -3.80M$ -1.54M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 19.58M$ 12.65M$ 11.46M$ 13.44M$ 16.92M
Total Assets$ 22.47M$ 15.57M$ 13.21M$ 14.91M$ 17.40M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -19.58M$ -12.65M$ -11.46M$ -13.44M$ -16.92M
Total Liabilities$ 2.83M$ 2.40M$ 1.47M$ 1.75M$ 646.46K
Stockholders Equity$ 19.77M$ 13.23M$ 11.77M$ 13.16M$ 16.75M
Cash Flow-
Free Cash Flow$ -3.13M$ -3.52M$ -2.09M$ -3.90M$ -1.46M
Operating Cash Flow$ -3.09M$ -3.52M$ -2.09M$ -3.90M$ -1.46M
Investing Cash Flow$ -38.91K---$ 0.00
Financing Cash Flow$ 10.07M$ 4.69M$ 118.92K$ 424.28K$ 0.00
Currency in USD

Immix Biopharma, Inc. Earnings and Revenue History

Immix Biopharma, Inc. Debt to Assets

Immix Biopharma, Inc. Cash Flow

Immix Biopharma, Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis